Uploaded October 2023 | Updated November 2026, 4 days ago
Edoxaban didn't significantly reduce cardiovascular death, stroke, or systemic embolism in patients with Atrial high-rate episodes. The treatment led to higher incidences of death or major bleeding.
State of Health Podcast: open.spotify.com/show/7JWc9FSny48WVhYr0GgBbn
Join this channel to get access to perks:
youtube.com/channel/UCUqgkmGj16aRxmVlHnDdVbw/join
Edoxaban didn't significantly reduce cardiovascular death, stroke, or systemic embolism in patients with Atrial high-rate episodes. The treatment led to higher incidences of death or major bleeding.
State of Health Podcast: open.spotify.com/show/7JWc9FSny48WVhYr0GgBbn
Join this channel to get access to perks:
youtube.com/channel/UCUqgkmGj16aRxmVlHnDdVbw/join










